Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2018, ended Jan 31, 2018 | — |
| FY2019, ended Jan 31, 2019 | — |
| FY2020, ended Jan 31, 2020 | $0 |
| FY2021, ended Jan 31, 2021 | $47.0B |
| FY2022, ended Jan 31, 2022 | $41.0B |
| FY2023, ended Jan 31, 2023 | $24.7B |
| FY2024, ended Jan 31, 2024 | $71.3B |
| FY2025, ended Jan 31, 2025 | $99.2B |
| FY2026, ended Jan 31, 2026 | $112B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $195B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2018, ended Jan 31, 2018 | $119M |
| FY2019, ended Jan 31, 2019 | $250M |
| FY2020, ended Jan 31, 2020 | $481M |
| FY2021, ended Jan 31, 2021 | $874M |
| FY2022, ended Jan 31, 2022 | $1.45B |
| FY2023, ended Jan 31, 2023 | $2.24B |
| FY2024, ended Jan 31, 2024 | $3.06B |
| FY2025, ended Jan 31, 2025 | $3.95B |
| FY2026, ended Jan 31, 2026 | $4.81B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $5.40B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2018, ended Jan 31, 2018 | −$135M | −$81.7M |
| FY2019, ended Jan 31, 2019 | −$140M | −$58.8M |
| FY2020, ended Jan 31, 2020 | −$142M | $19.7M |
| FY2021, ended Jan 31, 2021 | −$92.6M | $304M |
| FY2022, ended Jan 31, 2022 | −$235M | $463M |
| FY2023, ended Jan 31, 2023 | −$183M | $706M |
| FY2024, ended Jan 31, 2024 | $72.2M | $990M |
| FY2025, ended Jan 31, 2025 | −$15.2M | $1.13B |
| FY2026, ended Jan 31, 2026 | −$163M | $1.31B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $45.0M | $1.61B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2018, ended Jan 31, 2018 | $63.2M |
| FY2019, ended Jan 31, 2019 | $88.4M |
| FY2020, ended Jan 31, 2020 | $265M |
| FY2021, ended Jan 31, 2021 | $1.92B |
| FY2022, ended Jan 31, 2022 | $2.00B |
| FY2023, ended Jan 31, 2023 | $2.46B |
| FY2024, ended Jan 31, 2024 | $3.38B |
| FY2025, ended Jan 31, 2025 | $4.32B |
| FY2026, ended Jan 31, 2026 | $5.23B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $5.01B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2018, ended Jan 31, 2018 | — |
| FY2019, ended Jan 31, 2019 | — |
| FY2020, ended Jan 31, 2020 | $0 |
| FY2021, ended Jan 31, 2021 | $738M |
| FY2022, ended Jan 31, 2022 | $740M |
| FY2023, ended Jan 31, 2023 | $741M |
| FY2024, ended Jan 31, 2024 | $742M |
| FY2025, ended Jan 31, 2025 | $744M |
| FY2026, ended Jan 31, 2026 | $745M |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $746M |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 511% since FY18.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2018, ended Jan 31, 2018 | 168M |
| FY2019, ended Jan 31, 2019 | 190M |
| FY2020, ended Jan 31, 2020 | 0 |
| FY2021, ended Jan 31, 2021 | 871M |
| FY2022, ended Jan 31, 2022 | 909M |
| FY2023, ended Jan 31, 2023 | 933M |
| FY2024, ended Jan 31, 2024 | 975M |
| FY2025, ended Jan 31, 2025 | 997M |
| FY2026, ended Jan 31, 2026 | 1.02B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | 1.02B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Used in acquisitions |
|---|---|---|---|
| FY2018, ended Jan 31, 2018 | $0 | $12.3M | — |
| FY2019, ended Jan 31, 2019 | $2.33M | $20.5M | — |
| FY2020, ended Jan 31, 2020 | $0 | $79.9M | — |
| FY2021, ended Jan 31, 2021 | $0 | $150M | — |
| FY2022, ended Jan 31, 2022 | — | $310M | $3.53M |
| FY2023, ended Jan 31, 2023 | — | $527M | — |
| FY2024, ended Jan 31, 2024 | — | $649M | $4.31M |
| FY2025, ended Jan 31, 2025 | — | $861M | $3.56M |
| FY2026, ended Jan 31, 2026 | — | $1.10B | $9.20M |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | — | $1.24B | $6.14M |
Valuation
At current price- Market Cap
- $274B
- P/E
- 6099×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 50.9×
- Price / Book
- 53.8×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $5.40B
- Revenue Growth YoY
- 24.3%
- Revenue CAGR 3Y
- 29.0%
- Revenue CAGR 5Y
- 40.6%
- EPS Growth YoY
- n/m. Diluted EPS, TTM vs. TTM a year earlier
- Net Income Growth YoY
- n/m. TTM vs. TTM a year earlier
Profitability
Trailing 12 months- Gross Margin
- 75.2%
- Operating Margin
- −2.5%
- Net Margin
- 0.8%
- FCF Margin
- 29.8%
- Return on Equity
- 1.0%
Earnings
Trailing 12 months- Net Income
- $45.0M
- EPS (diluted)
- −$0.45
- EBITDA
- —. Operating income + depreciation & amortization
- Operating Income
- −$133M
Balance Sheet
As of Jul 31, 2026- Cash and cash equivalents
- $5.01B
- Total Debt
- $746M
- Net Cash
- $4.27B
- Total Assets
- $12.0B
- Total Liabilities
- $6.89B
- Shareholders' Equity
- $5.10B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $2.02B
- Capital Expenditure
- $408M
- Free Cash Flow
- $1.61B
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- 1.19
Every ratio is calculated from the company’s reported figures.